Enlivex Therapeutics Ltd (ENLV) — Net Asset Quality Index
Enlivex Therapeutics Ltd (ENLV) has a Net Asset Quality Index of 83.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA20.94 Million minus total liabilities of ILA3.46 Million yields net assets of ILA17.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Enlivex Therapeutics Ltd's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Enlivex Therapeutics Ltd Net Asset Quality Index Over Time (2012–2024)
This chart shows how Enlivex Therapeutics Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the index stands at 83.5%, representing net assets of ILA17.48 Million against total assets of ILA20.94 Million ILA. See ENLV working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Enlivex Therapeutics Ltd (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for Enlivex Therapeutics Ltd from 2012 to 2024, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Enlivex Therapeutics Ltd market cap and net worth.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.2% | ILA23.59 Million | ILA27.69 Million | ILA4.10 Million | ▲ +3.5 pp |
| 2023 | 81.7% | ILA30.08 Million | ILA36.83 Million | ILA6.75 Million | ▼ -2.4 pp |
| 2022 | 84.0% | ILA56.84 Million | ILA67.64 Million | ILA10.80 Million | ▼ -5.3 pp |
| 2021 | 89.4% | ILA85.04 Million | ILA95.15 Million | ILA10.11 Million | ▲ +1.4 pp |
| 2020 | 87.9% | ILA35.49 Million | ILA40.36 Million | ILA4.87 Million | ▲ +23.7 pp |
| 2019 | 64.2% | ILA11.28 Million | ILA17.56 Million | ILA6.28 Million | ▼ -23.7 pp |
| 2018 | 88.0% | ILA9.71 Million | ILA11.03 Million | ILA1.33 Million | ▲ +0.7 pp |
| 2017 | 87.3% | ILA3.16 Million | ILA3.62 Million | ILA460.00K | ▲ +5.5 pp |
| 2016 | 81.8% | ILA8.70 Million | ILA10.63 Million | ILA1.93 Million | ▼ -5.6 pp |
| 2015 | 87.4% | ILA17.93 Million | ILA20.52 Million | ILA2.58 Million | ▼ -5.7 pp |
| 2014 | 93.1% | ILA30.67 Million | ILA32.95 Million | ILA2.28 Million | ▼ -4.6 pp |
| 2013 | 97.7% | ILA5.55 Million | ILA5.69 Million | ILA131.00K | ▲ +49.6 pp |
| 2012 | 48.1% | ILA75.00K | ILA156.00K | ILA81.00K | — |